ADBE vs AMLX · P/E 11, rev $13.02B vs $561.6M cap
Adobe Systems Incorporated (ADBE) versus Amylyx Pharmaceuticals Inc (AMLX) — a side-by-side from cached financials, not a winner call.
Adobe Systems Incorporated (ADBE) is a software - application company listed on NASDAQ. It is led by Shantanu Narayen.
Amylyx Pharmaceuticals Inc (AMLX) is a biotechnology company listed on US.
Latest reported ADBE revenue for 2026-05-29 was $13.02B. Net income was $3.60B. ADBE currently screens at market cap $78.02B and trailing P/E 11.2.
Latest reported AMLX revenue for 2025-12-31 was $0. Net income was -$144.7M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. AMLX currently screens at market cap $561.6M.
ADBE currently screens at market cap $78.02B and trailing P/E 11.2. AMLX currently screens at market cap $561.6M.
Not investment advice. Open the ADBE and AMLX stock pages for the full models.
Not investment advice.